Anti-hyperglycemic and anti-hyperlipidaemic effect of Arjunarishta in high-fat fed animals

Maniyar, 2012, Antihyperglycemic and hypolipidemic activities of aqueous extract of Carica papaya Linn. leaves in alloxan-induced diabetes rats, J Ayurveda Integr Med, 3, 70, 10.4103/0975-9476.96519 Gaballu, 2015, Effects of a triplex mixture of Peganum harmala, Rhuscoriaria, and Urticadioica aqueous extracts on metabolic and histological parameters in diabetes rats, Pharm Biol, 53, 1104, 10.3109/13880209.2014.960943 Tang, 2004, Ischemic heart disease and congestive heart failure in diabetes patients, Med Clin North Am, 88, 1037, 10.1016/j.mcna.2004.04.008 Datta, 2013, Antidiabetes and antihyperlipidemic activity of hydroalcoholic extract of Withania coagulans Dunal dried fruit in experimental rat models, J Ayurveda Integr Med, 4, 99, 10.4103/0975-9476.113880 Singh, 2008, Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity, J Ethnopharmacol, 117, 123, 10.1016/j.jep.2008.01.022 Amalraj, 2017, Medicinal properties of Terminalia arjuna (Roxb.) Wight &Arn.: a review, J Tradit Complement Med, 7, 65, 10.1016/j.jtcme.2016.02.003 Subramaniam, 2011, Anti-Atherogenic activity of ethanolic fraction of Terminalia arjuna bark on hypercholesterolemic rabbits, Evid Based Complement Altern Med, 10.1093/ecam/neq003 Bharani, 1995, Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure, Int J Cardiol, 49, 191, 10.1016/0167-5273(95)02320-V Gauthaman, 2005, Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: role of antioxidant enzymes and heat shock protein, J Ethnopharmacol, 96, 403, 10.1016/j.jep.2004.08.040 Raghavan, 2006, Effect of Terminalia arjuna stem bark on antioxidant status in liver and kidney of alloxan diabetes rats, Indian J physiol Pharmacol, 50, 133 Lele, 2010, Beyond reverse pharmacology: mechanism-based screening of Ayurvedic drugs, J Ayurveda Integr Med, 1, 257, 10.4103/0975-9476.74435 Halder, 2009, Anti-inflammatory, immunomodulatory and antinociceptive activity of Terminalia arjuna Roxb bark powder in mice and rats, Indian J Exp Biol, 47, 577 Jain, 2009, Terminalia arjuna a sacred medicinal plant: phytochemical and pharmacological profile, Phytochem Rev, 8, 491, 10.1007/s11101-009-9134-8 Ragini, 2012, An approach to standardize Arjunarishta: a well known ayurvedic formulation using UV and Colorimetric method, J Med Pharm Allied Sci, 01, 77 Lal, 2009, HPLC analysis and standardization of Arjunarishta – an Ayurvedic cardioprotective formulation, Sci Pharm, 77, 605, 10.3797/scipharm.0906-03 Chitlange, 2009, High- fingerprint for quality control of Terminalia arjuna containing Ayurvedic churna formulation, J AOAC Int, 92, 1016 Ghosh, 2015 Wu, 2015, Protective effects of grape seed extract fractions with different degrees of polymerisation on blood glucose, lipids and hepatic oxidative stress in diabetes rats, Nat Prod Res, 29, 988, 10.1080/14786419.2014.965165 Sattar, 2011, Antihyperglycaemic and hypolipidaemic effects of the methanolic extract of Caralluma tuberculata in streptozotocin-induced diabetes rats, Nat Prod Res, 25, 1171, 10.1080/14786419.2010.490782 Lee, 2008, Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys, Eur J Pharmacol, 589, 306, 10.1016/j.ejphar.2008.04.047 Deshpande, 2013, Anti-obesity activity of Ziziphus mauritiana: a potent pancreatic lipase inhibitor, Asian J Pharm Clin Res, 6, 168 Hardikar, 2015, Multigenerational undernutrition increases susceptibility to obesity and diabetes that is not reversed after dietary recuperation, Cell Metab, 22, 312, 10.1016/j.cmet.2015.06.008 Mopuri, 2015, Evaluation of anti-obesity activities of ethanolic extract of Terminalia paniculata bark on high fat diet-induced obese rats, BMC Complement Altern Med, 15, 76, 10.1186/s12906-015-0598-3 Simsek, 2012, Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes—the CORALL study, Diabet Med, 29, 628, 10.1111/j.1464-5491.2011.03553.x Parveen, 2011, Antidiabetes effects afforded by Terminalia arjuna in high fat-fed and streptozotocin-induced type 2 diabetes rats, Int J Diabetes Metab, 19, 23 Ram, 1997, Hypocholesterolaemic effects of Terminalia arjuna tree bark, J Ethnopharmacol, 55, 165, 10.1016/S0378-8741(96)01493-6 Nigam, 2008, Effect of rosuvastatin on methionine-induced hyperhomocysteinaemia and haematological changes in rats, Basic Clin Pharmacol Toxicol, 103, 287, 10.1111/j.1742-7843.2008.00293.x Dwivedi, 1994, Antianginal and cardioprotective effects of Terminalia arjuna an indigenous drug in coronary artery disease, J Assoc Physicians India, 42, 287 Sandhu, 2010, Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults, Int J Ayurveda Res, 1, 144, 10.4103/0974-7788.72485 Khaliq, 2013, Improvement in myocardial function by Terminalia arjuna in streptozotocin-induced diabetes rats: possible mechanisms, J Cardiovasc Pharmacol Ther, 18, 481, 10.1177/1074248413488831 Shimabukuro, 1998, Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes, Proc Natl Acad Sci U S A, 95, 2498, 10.1073/pnas.95.5.2498 McGarry, 2002, Banting lecture: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes, Diabetes, 51, 7, 10.2337/diabetes.51.1.7 Parveen, 2011, Mechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats, Cardiovasc Toxicol, 11, 48, 10.1007/s12012-010-9099-2 Swaroop, 2012, TNF-α with insulin resistance in type 2 diabetes mellitus, Stud IJMR Assoc, 127 Joshi, 2010, Cinnamomum zeylanicum extract inhibits proinflammatory cytokine TNF∝: in vitro and in vivo studies, Res Pharm Biotechnol, 2, 14 Borst, 2005, High-fat diet induces increased tissue expression of TNF-alpha, Life Sci, 77, 2156, 10.1016/j.lfs.2005.03.021 Liang, 2006, PGC-1alpha: a key regulator of energy metabolism, Adv Physiol Educ, 30, 145, 10.1152/advan.00052.2006 Handschin, 2006, Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis and metabolism, Endocr Rev, 27, 728, 10.1210/er.2006-0037 Sumantran, 2012, Cancer, inflammation, and insights from ayurveda, Evid Based Complement Altern Med, 10.1155/2012/306346 Gupta, 2011, Ethanolic extract of cinnamon potentiates in vitro pparγ reporter activity in presence of pgc1α and src1 and improves glucose tolerance in mice, Int Res J Biotechnol, 2, 47 Olsson, 2002, Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor, Cardiovasc Drug Rev, 20, 303, 10.1111/j.1527-3466.2002.tb00099.x Wang, 2010, Statins enhance peroxisome proliferator-activated receptor gamma coactivator-1alpha activity to regulate energy metabolism, J Mol Med (Berl), 88, 309, 10.1007/s00109-009-0561-1 Manna, 2010, Streptozotocin induced activation of oxidative stress responsive splenic cell signaling pathways: protective role of arjunolic acid, Toxicol Appl Pharmacol, 244, 114, 10.1016/j.taap.2009.12.024